Life Sciences » tagged “FDA guidance”

FDA proposes guidance to clarify risk-benefit determinations for medical devices

The U.S. Food and Drug Administration has provided draft guidance clarifying how benefit-risk determinations are made during premarket review of certain medical devices. The guidance focuses on premarket approval applications (PMAs), the regulatory pathway for high-risk medical devices.

Continue reading »